NFKB1 and neoplasm: This might not be surprising, because in tumor cells, treatment with proteasome inhibitors prevents NF-κB activation and leads to toxic accumulation of misfolded proteins, which in turn activates JNK1 and apoptosis [80], whereas S. mansoni does not have an NF-κB homolog.